X-rays Indicates Kolla2® Effective in Improving Joint Health in Canine Models

X-rays Indicates Kolla2® Effective in Improving Joint Health in Canine Models Long-term micro-research finds that after taking Kolla2®, a canine diagnosed with hip Dysplasia resumed its normal mobility, and an X-ray showed normal hip joint cartilage.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. Research Demonstrates Value of Glyco-Flex(R) for Canine Joint Support Washington State University researchers released results from three studies that strongly suggest that Glyco-Flex III, an animal health product formulated by Vetri-Science Laboratories of Vermont, is a safe and beneficial option for use in dogs requiring joint support. Research Demonstrates Value of Glyco-Flex(R) for Canine Joint Support Washington State University researchers released results from three studies that strongly suggest that Glyco-Flex III, an animal health product formulated by Vetri-Science Laboratories of Vermont, is a safe and beneficial option for use in dogs requiring joint support. Research Demonstrates Value of Glyco-Flex(R) for Canine Joint Support Washington State University researchers released results from three studies that strongly suggest that Glyco-Flex III, an animal health product formulated by Vetri-Science Laboratories of Vermont, is a safe and beneficial option for use in dogs requiring joint support. Research Demonstrates Value of Glyco-Flex(R) for Canine Joint Support Washington State University researchers released results from three studies that strongly suggest that Glyco-Flex III, an animal health product formulated by Vetri-Science Laboratories of Vermont, is a safe and beneficial option for use in dogs requiring joint support. Study Examines the Effect of Functional Keratin On Equine Lameness Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo. Study Examines the Effect of Functional Keratin On Equine Lameness Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo. Study Examines the Effect of Functional Keratin On Equine Lameness Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo. Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets. Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets. Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets. Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets. Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Lake Forest, California, Thursday March 9, 2006 – Collagen Nutraceuticals is pleased to announce the results of long-term micro-research investigating the use of kolla2® for joint health. The research finds that after taking Kolla2®, a canine diagnosed with hip Dysplasia resumed its normal mobility, and an X-ray showed normal hip joint cartilage. Hip Dysplasia is the malformation of the hip joints causing subsequent mobility limitations. Hip Dysplasia is characterized by looseness in the hip joint that causes abnormal wear and tear on the femoral head (the ball part of this ball and socket joint) and the acetabulum (the socket). The wear and tear can cause arthritis. Hip pain is generated from the abnormal arthritic bones rubbing against each other. Arthritis will worsen with time. Veterinarians and researchers were amazed with the results after examining a canine subject’s X-rays. At the time of diagnosis in 1999, after seeing X-rays showing “bilateral incongruity of joints”, the veterinary surgical examiner determined the dog (an Airedale Terrier) had “definite bilateral hip dysplasia.” It was determined that the dog would face “significant osteophyte formation relatively soon, and surgery was recommended.” Six years following continual daily supplementation with ArthroPet™, a dietary supplement formula whose main active ingredient is Kolla2®, the same examiners were surprised to find that there was “definite filling-in of bilateral femoral necks” with the dog having clinically normal mobile activity. The filling-in is cartilage. Elderly canine subjects from a local shelter were also found to become viable pets again for adoption within a short period of time after using ArthroPet™, by markedly increasing their comfort and improving stiffness in their limbs. An additional canine subject with osteoarthritis and a missing leg was placed on ArthroPet™ by his veterinarian and was found to have his comfort and mobility level “improved at least 75% over his previous condition” after supplementing with ArthroPet™ for about six months. Based on these preliminary findings, additional canines are being recruited to be subjects of a larger clinical trial. Ongoing research on additional canines is sponsored by NeoCell Corporation (Newport Beach, CA) a leader in collagen research and supplementation since 1985, Collagen Nutraceuticals and AIDP, the exclusive sales representative of Kolla2® raw material in North America. NeoCell developed the innovative ArthroPet™ collagen formula for Canine and Equine supplementation (patent pending). Only ArthroPet™ brand was used in the research on the canine subjects. ArthroPet™ contains the active ingredient kolla2® collagen type II (U.S. Patent Number 6,838,440). For additional information and product availability, please contact our exclusive raw materials partner for North America - AIDP, Inc. Toll-free 1-866-262-6699, Tel – 626-964-6910, Fax 626-964-6739, www.aidp.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software